CECXG
CECXG, also recognized as 3'-ethyl-LY-341,495, is a specialized research drug of significant interest within the field of neuropharmacology. Its unique properties make it a potentially valuable tool for researchers studying the group II metabotropic glutamate receptors (mGluR2/3). Its ability to differentiate between mGluR2 and mGluR3, two closely related receptor subtypes, has garnered attention within the research community.
Pharmacological Profile[edit | edit source]
- Target Receptors: Group II metabotropic glutamate receptors (mGluR2/3).
- Action: Acts as an antagonist, which means it blocks or inhibits the function of the receptor it binds to.
Selectivity and Potency[edit | edit source]
- mGluR3 Selectivity: CECXG displays reasonable selectivity for mGluR3 over mGluR2, boasting an affinity that's 38 times higher for mGluR3 than for mGluR2. This distinctive feature places CECXG among the rare ligands capable of distinguishing between these two receptor subtypes.
- Comparison with LY-341,495: Although CECXG is roughly five times less potent than LY-341,495 at mGluR3, its enhanced specificity for mGluR3 over mGluR2 sets it apart.
Applications in Research[edit | edit source]
Given its unique characteristics, CECXG presents itself as a valuable compound for:
- Neuropharmacology research: To understand the roles and functions of mGluR2 and mGluR3 in the nervous system.
- Drug development: Could serve as a foundational molecule for the development of drugs targeting these receptors.
- Neurological disorders: To study the implications of mGluR2/3 in various neurological and psychiatric disorders.
Conclusion[edit | edit source]
CECXG's distinct pharmacological profile and its ability to selectively target and differentiate between mGluR2 and mGluR3 make it an invaluable tool in neuropharmacological research. While its full potential and applications are still under exploration, CECXG is a promising molecule that can yield insights into the functions of these metabotropic glutamate receptors and their implications in various conditions.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
